|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 3.730 USD | -4.85% |
|
-13.05% | -67.98% |
| 08-13 | ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises | MT |
| 08-13 | ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
| Market Cap | 371M 333M 307M 279M 521M 35.23B 527M 3.69B 1.46B 18.47B 1.39B 1.36B 58.56B | P/E 2026 * |
-2.01x | P/E 2027 * | -4.41x |
|---|---|---|---|---|---|
| Enterprise Value | 371M 333M 307M 279M 521M 35.23B 527M 3.69B 1.46B 18.47B 1.39B 1.36B 58.56B | EV / Sales 2026 * |
2.88x | EV / Sales 2027 * | 1.98x |
| Free-Float |
83.82% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SPRY | Delayed | |
CBOE
| SPRY | Real-time |
Last Transcript: ARS Pharmaceuticals, Inc.
| 1 day | -4.85% | ||
| 1 week | -13.05% | ||
| Current month | -13.46% | ||
| 1 month | -8.58% | ||
| 3 months | -35.24% | ||
| 6 months | -53.08% | ||
| Current year | -67.98% |
| 1 week | 3.64 |  | 4.36 |
| 1 month | 3.64 | | 4.64 |
| Current year | 3.64 | | 13.15 |
| 1 year | 3.64 | | 13.15 |
| 3 years | 3.38 | | 18.9 |
| 5 years | 2.55 | | 18.9 |
| 10 years | 2.55 | | 18.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bell
CTO | Chief Tech/Sci/R&D Officer | - | 2015-08-04 |
Donn Casale
CEO | Chief Executive Officer | 53 | 2026-07-06 |
Kathleen Scott
DFI | Director of Finance/CFO | 57 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Pratik Shah
CHM | Chairman | 56 | 2022-11-07 |
Rajeev Dadoo
BRD | Director/Board Member | 55 | 2021-07-31 |
Saqib Islam
BRD | Director/Board Member | 56 | 2017-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/1/26 | Free | Chief Executive Officer | 1,036,923 | 1.0427% | ||
| 9/1/26 | Free | Executive/Senior Manager | 1,001,738 | 1.0073% | ||
| 7/1/26 | Free | Chief Executive Officer | 898,456 | 0.9048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -13.05% | -60.98% | +7.49% | 371M | |
| -3.10% | -4.19% | +32.67% | +59.47% | 63.48B | |
| +0.33% | +0.33% | +10.16% | +78.07% | 54.55B | |
| +0.16% | +1.73% | +9.89% | +102.10% | 53.59B | |
| -0.75% | +1.38% | +24.89% | +50.91% | 44.75B | |
| -1.30% | -4.80% | +16.05% | +114.76% | 41.62B | |
| +1.26% | -5.26% | +221.12% | +900.64% | 39.91B | |
| -0.74% | -4.46% | +11.00% | +44.65% | 32.47B | |
| +1.11% | +15.18% | +60.27% | +49.33% | 26.7B | |
| +3.99% | -6.03% | +26.28% | -8.08% | 23.36B | |
| Average | -0.39% | -2.38% | +35.13% | +139.93% | 38.08B | |
| Weighted average by Cap. | -0.29% | -1.28% | +42.87% | +155.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 129M 115M 107M 96.63M 181M 12.21B 183M 1.28B 507M 6.4B 483M 472M 20.3B | 187M 168M 155M 141M 263M 17.77B 266M 1.86B 738M 9.32B 702M 687M 29.54B |
| Net income | -185M -166M -153M -139M -260M -17.56B -263M -1.84B -730M -9.21B -694M -679M -29.19B | -85.17M -76.44M -70.58M -64M -120M -8.09B -121M -846M -336M -4.24B -320M -313M -13.45B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | US$3.730 | -4.85% | 1,643,512 |
| 26-10-26 | US$3.920 | -2.73% | 1,433,831 |
| 26-10-23 | US$4.030 | -6.71% | 1,522,195 |
| 26-10-22 | US$4.320 | +3.35% | 1,787,746 |
| 26-10-21 | US$4.180 | -2.56% | 1,010,610 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SPRY Stock
Select your edition
All financial news and data tailored to specific country editions
